Folic acid‐PEG conjugated superparamagnetic nanoparticles for targeted cellular uptake and detection by MRI
- 30 May 2006
- journal article
- research article
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 78A (3), 550-557
- https://doi.org/10.1002/jbm.a.30781
Abstract
We report the development and in vitro study of a nanoconjugate serving as a targeted magnetic resonance imaging (MRI) contrast enhancement agent for detection of cancer cells overexpressing the folate receptor. The nanoconjugate was synthesized by coating superparamagnetic iron oxide nanoparticles with covalently bound bifunctional poly(ethylene glycol) (PEG), followed by conjugation with folic acid (FA). The specificity of the nanoconjugate targeting cancerous cells was demonstrated by comparative intracellular uptake of the nanoconjugate and PEG-/dextran-coated nanoparticles by human adenocarcinoma HeLa cells. Preferential targeting to cancerous cells was studied by comparing the uptake of the nanoconjugate by HeLa cells and by non-FR expressing osteosarcoma MG-63 cells. Uptake of the nanoconjugate by HeLa cells after 4 h incubation was found to be a 12-fold higher than that of PEG- or dextran-coated nanoparticles as quantified by inductively coupled plasma spectroscopy. A significant negative contrast enhancement was observed with magnetic resonance (MR) phantom imaging for HeLa cells over MG-63 cells, when both were cultured with the nanoconjugate. Specificity of the nanoconjugate for folate receptors was also verified with a competitive inhibition assay, in which HeLa cells were incubated with both NP–PEG–FA and free FA. The bifunctional PEG used has amide linkages within the PEG chains that can form interchain hydrogen bonding, leading to improved stability of the PEG coating. Self-assembled PEG can be controlled at the molecular level and are suitable for nanoscale coatings. © 2006 Wiley Periodicals, Inc. J Biomed Mater Res, 2006Keywords
This publication has 32 references indexed in Scilit:
- Synthesis and surface engineering of iron oxide nanoparticles for biomedical applicationsBiomaterials, 2005
- Nanotechnology for the biologistJournal of Leukocyte Biology, 2005
- Nanoscale Size Effect of Magnetic Nanocrystals and Their Utilization for Cancer Diagnosis via Magnetic Resonance ImagingJournal of the American Chemical Society, 2005
- Characterization of aqueous dispersions of Fe3O4 nanoparticles and their biomedical applicationsBiomaterials, 2005
- The preparation of magnetic nanoparticles for applications in biomedicineJournal of Physics D: Applied Physics, 2003
- mRNA Instability in the Nucleus Due to a Novel Open Reading Frame Element Is a Major Determinant of the Narrow Tissue Specificity of Folate Receptor αMolecular and Cellular Biology, 2003
- Preparation of ultrafine silica- and PEG-coated magnetite particlesColloids and Surfaces A: Physicochemical and Engineering Aspects, 2001
- Targeting of ultrasmall superparamagnetic iron oxide (USPIO) particles to tumor cells in Vivo by using transferrin receptor pathwaysMagnetic Resonance in Medicine, 1998
- Antibody-magnetite nanoparticles: In vitro characterization of a potential tumor-specific contrast agent for magnetic resonance imagingBioconjugate Chemistry, 1993
- Monoclonal antibody‐coated magnetite particles as contrast agents in magnetic resonance imaging of tumorsMagnetic Resonance in Medicine, 1989